NCT01994096View on ClinicalTrials.gov

Optimal Dosage of Caspofungin in Critically Ill Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Critically IllSuspected Invasive Candidiasis
Interventions
DRUG

Caspofungin

Trial Locations (1)

9700 RB

University Medical Centre Groningen, Groningen

All Listed Sponsors
lead

University Medical Center Groningen

OTHER

NCT01994096 - Optimal Dosage of Caspofungin in Critically Ill Patients | Biotech Hunter | Biotech Hunter